Literature DB >> 25337287

Neuroendocrine liver metastasis in gastric mixed adenoneuroendocrine carcinoma with trilineage cell differentiation: a case report.

Wenjin Zhang1, Weihua Xiao2, Haifen Ma2, Mingfei Sun2, Hongtan Chen1, Shusen Zheng1.   

Abstract

Mixed adenoneuroendocrine carcinoma (MANEC) is a rare disease, which mostly occurs in the gastrointestinal tract and pancreas. Here we report a case of gastric MANEC with tri-lineage differentiation in which only the neuroendocrine component had metastasized to the liver. Liver and gastric masses were detected by abdominal computed tomography, and the preoperative relationship between liver and gastric masses was unknown. The histopathological analysis after operation confirmed the gastric mass to be MANEC, whereas the liver mass was actually the metastatic neuroendocrine component of the gastric MANEC. In the pathologic diagnosis, tri-lineage differentiation, including tubular adenocarcinoma, neuroendocrine carcinoma and squamous cell carcinoma was observed in the gastric MANEC tissues. The mitotic and Ki-67 labeling indexes of the resected tumor tissue were high, and thus, the tumor was classified as a grade G3 neuroendocrine carcinoma, which has a poor prognosis. Multiple low-density masses were found in the right lobe of the liver 2.5 months after operation.

Entities:  

Keywords:  Mixed adenoneuroendocrine carcinoma; differentiation; gastroenteropancreatic neuroendocrine tumor; immunohistochemistry

Mesh:

Substances:

Year:  2014        PMID: 25337287      PMCID: PMC4203258     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  14 in total

1.  Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.

Authors:  Jung Ho Kim; Ye-Young Rhee; Jeong Mo Bae; Nam-Yun Cho; Gyeong Hoon Kang
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

2.  CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary.

Authors:  Mohamed Mokhtar Desouki; Joshua Lioyd; Haodong Xu; Dengfeng Cao; Ross Barner; Chengquan Zhao
Journal:  Hum Pathol       Date:  2013-09-09       Impact factor: 3.466

Review 3.  Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

Authors:  U Plöckinger; G Rindi; R Arnold; B Eriksson; E P Krenning; W W de Herder; A Goede; M Caplin; K Oberg; J C Reubi; O Nilsson; G Delle Fave; P Ruszniewski; H Ahlman; B Wiedenmann
Journal:  Neuroendocrinology       Date:  2005-04-18       Impact factor: 4.914

4.  High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases.

Authors:  Hind Nassar; Jorge Albores-Saavedra; David S Klimstra
Journal:  Am J Surg Pathol       Date:  2005-05       Impact factor: 6.394

5.  Microallelotyping defines the monoclonal or the polyclonal origin of mixed and collision endocrine-exocrine tumors of the gut.

Authors:  Daniela Furlan; Roberta Cerutti; Anna Genasetti; Giuseppe Pelosi; Silvia Uccella; Stefano La Rosa; Carlo Capella
Journal:  Lab Invest       Date:  2003-07       Impact factor: 5.662

6.  Primary esophageal small cell carcinoma with concomitant invasive squamous cell carcinoma or carcinoma in situ.

Authors:  Junya Yamamoto; Koichi Ohshima; Seiyou Ikeda; Akinori Iwashita; Masahiro Kikuchi
Journal:  Hum Pathol       Date:  2003-11       Impact factor: 3.466

7.  Primary endocrinomas (carcinoids and variant neoplasms) of the gallbladder. A statistical evaluation of 138 reported cases.

Authors:  J Soga
Journal:  J Exp Clin Cancer Res       Date:  2003-03

8.  Gastric mixed adenoneuroendocrine carcinoma with a trilineage cell differentiation: case report and review of the literature.

Authors:  Marinos Pericleous; Christos Toumpanakis; Heather Lumgair; Martyn E Caplin; Luke Morgan-Rowe; Ian Clark; Tu Vinh Luong
Journal:  Case Rep Oncol       Date:  2012-06-12

9.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

10.  Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy.

Authors:  Wu Song; Wenfang Chen; Sheng Zhang; Jianjun Peng; Yulong He
Journal:  Diagn Pathol       Date:  2012-11-27       Impact factor: 2.644

View more
  8 in total

1.  Pancreatic-type Mixed Acinar-neuroendocrine Carcinoma of the Stomach: A Case Report and Literature Review.

Authors:  James Saller; Brooke Hough; Domenico Coppola
Journal:  Cancer Diagn Progn       Date:  2021-07-03

2.  A case of mixed adenoneuroendocrine carcinoma of the pancreas: Immunohistochemical analysis for histogenesis.

Authors:  Masaru Murata; Hidekazu Takahashi; Moyuru Yamada; Misa Song; Masahiro Hiratsuka
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

3.  Multiregion Comprehensive Genomic Profiling of a Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Trilineage Differentiation.

Authors:  Faheem Farooq; Kevin Zarrabi; Keith Sweeney; Joseph Kim; Jela Bandovic; Chiraag Patel; Minsig Choi
Journal:  J Gastric Cancer       Date:  2018-06-11       Impact factor: 3.720

4.  Gastric adenocarcinoma is concurrent with metastatic neuroendocrine cancer treated with nivolumab and chemotherapy: A case report.

Authors:  Bing Yan; Meiqi Cui; Junhao You; Fang Li; Hui Liu
Journal:  Mol Clin Oncol       Date:  2018-10-05

5.  Efficacy of XELOX adjuvant chemotherapy for gastric mixed adenoneuroendocrine carcinoma: A case report.

Authors:  Zhixian Lin; Jiangfeng Chen; Yong Guo
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

6.  Correlation of metastasis characteristics with prognosis in gastric mixed adenoneuroendocrine carcinoma: Two case reports.

Authors:  Qiang Tang; Zili Zhou; Jinhuang Chen; Maojun Di; Jintong Ji; Wenzheng Yuan; Zhengyi Liu; Liang Wu; Xudan Zhang; Kang Li; Xiaogang Shu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 7.  Mixed Neuroendocrine Non-Neuroendocrine Neoplasms: A Systematic Review of a Controversial and Underestimated Diagnosis.

Authors:  Melissa Frizziero; Bipasha Chakrabarty; Bence Nagy; Angela Lamarca; Richard A Hubner; Juan W Valle; Mairéad G McNamara
Journal:  J Clin Med       Date:  2020-01-19       Impact factor: 4.241

8.  Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm.

Authors:  Panpan Zhang; Zhongwu Li; Jie Li; Jian Li; Xiaotian Zhang; Zhihao Lu; Yu Sun; Yan Li; Jun Zhou; Xicheng Wang; Zhi Peng; Lin Shen; Ming Lu
Journal:  Cancer Med       Date:  2021-06-10       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.